Alexion Pharmaceuticals Inc Sample Contracts
By and AmongMerger Agreement • October 3rd, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
and THE CHASE MANHATTAN BANK as Trustee INDENTUREIndenture • May 10th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
1. Certain Definitions............................................. 1 2. Appointment of Rights Agent..................................... 10 4. Form of Right Certificates...................................... 14 5. Countersignature and...Rights Agreement • February 21st, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 1 3,600,000 Shares of Common Stock ALEXION PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 12th, 2003 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
and -License Agreement • April 9th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EXHIBIT 4(b) ALEXION PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT AGREEMENT made as of the ___ day of _________, 199__, by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company") and _____________________ (the...Incentive Stock Option Agreement • April 9th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
PURCHASE AGREEMENT ------------------ October 26, 2000 U.S. BANCORP PIPER JAFFRAY Piper Jaffray Tower 222 South Ninth Street Minneapolis, Minnesota 55402 Ladies and Gentlemen: Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"),...Purchase Agreement • October 27th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Minnesota
Exhibit 1.1 ----------- JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on this Schedule 13G/A, dated May 1, 2003, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.0001 per share, of Alexion...Joint Filing Agreement • May 2nd, 2003 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13G/A, dated May 1, 2003, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.0001 per share, of Alexion Pharmaceuticals, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G/A. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G/A, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of April 1, 1997 by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Leonard Bell, M.D. (the "Executive"). W I T N E S S E T H WHEREAS, the...Employment Agreement • April 4th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of April 1, 2000 by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Leonard Bell, M.D. (the "Executive"). W I T N E S S E T H WHEREAS, the...Employment Agreement • June 13th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement") is dated as of March 8, 2000, by and among ALEXION PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), J.P. MORGAN SECURITIES INC., U.S. BANCORP...Registration Rights Agreement • July 18th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of October 22, 1997, by and between ALEXION Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Louis A. Matis (the "Executive"). W I T N E S S E T H WHEREAS, the...Employment Agreement • October 28th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
CONFIDENTIAL TREATMENT MEMORANDUM OF UNDERSTANDING Revised P&GP / Alexion Pexelizumab Collaboration This Memorandum represents a summary of the Parties' interests in renegotiating their current Collaboration and it is binding as set forth in the final...Memorandum of Understanding • October 29th, 2002 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 4.1 EMPLOYMENT AGREEMENT THIS AGREEMENT, dated September 21, 2000, by and between Alexion Pharmaceuticals, Inc., a Delaware Corporation (the "Company"), and Katherine S. Bowdish, Ph.D., an individual resident of [California] ("Executive")....Employment Agreement • October 3rd, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Amendment toCollaboration Agreement • November 19th, 1999 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 10.1 AMENDMENT NO. 2 TO RIGHTS AGREEMENT This AMENDMENT NO. 2 RIGHTS AGREEMENT (the "Amendment") is made as of December 12, 2001 between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Continental Stock Transfer &...Rights Agreement • February 12th, 2002 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 4.2 ALEXION PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT ---------------------- AGREEMENT made as of the ____ day of _________ 1998 by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company") and (the "Optionee"). W I...Stock Option Agreement • February 8th, 1999 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of March 7, 2011 among ALEXION PHARMACEUTICALS, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, THE OTHER LENDERS PARTY HERETO, MERRILL LYNCH, PIERCE, FENNER & SMITH...Credit Agreement • March 10th, 2011 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This SECOND AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of March 7, 2011, among ALEXION PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and J.P. MORGAN SECURITIES INC., as Joint Lead Arrangers and Joint Book Managers.
by and betweenAsset Purchase Agreement • November 19th, 1999 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT Dated as of February 7, 2012 among ALEXION PHARMACEUTICALS, INC., as the Administrative Borrower, BANK OF AMERICA, N.A., as Administrative Agent, THE OTHER LENDERS PARTY HERETO, JPMORGAN CHASE BANK, N.A., as Syndication Agent MERRILL...Credit Agreement • February 7th, 2012 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT (“Agreement”) is entered into as of February 7, 2012, among ALEXION PHARMACEUTICALS, INC., a Delaware corporation (the “Administrative Borrower”), certain Subsidiaries of the Administrative Borrower party hereto pursuant to Section 2.15 (each a “Designated Borrower” and, together with the Administrative Borrower, the “Borrowers” and, each a “Borrower”); each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and J.P. MORGAN SECURITIES LLC, as joint lead arrangers and joint book managers.
SECTION A THIS AGREEMENT (the "Agreement") is made this 22nd day of December 1999 (the "Effective Date") by and between GENZYME TRANSGENICS CORPORATION ("GTC"), with offices at 175 Crossing Boulevard, Framingham, Massachusetts 01702-9322 U.S.A. and...Research and Development • March 15th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Confidential treatment has been requested for portions of this exhibit. The confidential portions have been redacted and are denoted by [______________]. The confidential portions have been separately filed with the commission.] AMENDMENT TO JOINT...Joint Development Agreement • October 9th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of October 22, 1997, by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and David Keiser (the "Executive"). W I T N E S S E T H WHEREAS, the...Employment Agreement • October 28th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Exhibit 4.2 THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933 (THE "SECURITIES ACT"), AND THIS SECURITY AND THE SHARES OF COMMON STOCK ISSUABLE UPON...Security Agreement • May 10th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENT dated as of January 25, 2005 between ALEXION PHARMACEUTICALS, INC. and MORGAN STANLEY & CO. INCORPORATED, BEAR, STEARNS & CO. INC., SG COWEN & CO., LLC andRegistration Rights Agreement • January 25th, 2005 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT dated as of January 25, 2005, between Alexion Pharmaceuticals, Inc., a Delaware corporation (the Company”), and Morgan Stanley & Co. Incorporated, Bear, Stearns & Co. Inc., SG Cowen & Co., LLC, and J.P. Morgan Securities Inc. as the initial purchasers (the “Initial Purchasers”) pursuant to the Purchase Agreement dated January 19, 2005 (the “Purchase Agreement”) between the Company and the Initial Purchasers. In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement.
RECITALSNon-Exclusive License Agreement • April 9th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AMENDED AND RESTATED CREDIT AGREEMENT Dated as of January 22, 2010 among ALEXION PHARMACEUTICALS, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, THE OTHER LENDERS PARTY HERETO, BANC OF AMERICA SECURITIES LLC and J.P. MORGAN...Credit Agreement • February 23rd, 2010 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of January 22, 2010, among ALEXION PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, BANC OF AMERICA SECURITIES LLC and J.P. MORGAN SECURITIES INC., as Joint Lead Arrangers, and BANC OF AMERICA SECURITIES LLC as Lead Book Manager.
Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement") dated as of October 2, 2000, by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and David Keiser (the "Executive"). W I T N E S S E T H...Employment Agreement • October 6th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EXHIBIT 4(c) ALEXION PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT AGREEMENT made as of the _________________ day of _________ 199_ by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company") and ____________________ (the...Stock Option Agreement • April 9th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • October 6th, 2000 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • October 23rd, 2019 • Alexion Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) dated as of September 17, 2019 by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on behalf of itself and its subsidiaries, related and affiliated companies, and all of their respective divisions, successors, and assigns (collectively, Alexion”), and Aradhana Sarin (the “Employee”).
FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • September 17th, 2010 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of , 2010, by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and (“Indemnitee”).
LICENSE AND COLLABORATIVE RESEARCH AGREEMENT BETWEEN ALEXION PHARMACEUTICALS, INC. AND GENETIC THERAPY, INC.License and Collaborative Research Agreement • April 4th, 1997 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Alexion Pharmaceuticals, Inc. Common Stock Underwriting Agreement May 24, 2012Underwriting Agreement • May 29th, 2012 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 5,000,000 shares (the “Securities”) of Common Stock, $0.0001 par value per share (“Stock”), of the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • February 16th, 2006 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
This EMPLOYMENT AGREEMENT (the “Agreement”) dated as of ___________ by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ______________ (the “Employee”).